CPT® Code 83898

Deleted

1. Indications

The molecular diagnostics test using target amplification is indicated for a variety of clinical scenarios, including:

• Cancer Diagnosis This test is utilized to identify specific genetic mutations or alterations associated with various types of cancer, aiding in accurate diagnosis and treatment planning.
• Infection Detection Molecular diagnostics can detect the presence of pathogens, such as bacteria or viruses, by amplifying their nucleic acid sequences, which is critical for timely and appropriate treatment.
• Hematological Disorders The test is indicated for diagnosing blood-related disorders by identifying genetic changes that may affect blood cell function or production.
• Neurological Disorders It assists in diagnosing genetic conditions that impact the nervous system, providing insights into potential therapeutic approaches.
• Inherited Genetic Disorders The test is used to identify genetic mutations that may be passed from parents to offspring, facilitating early diagnosis and management of hereditary conditions.

2. Procedure

The procedure for molecular diagnostics using target amplification involves several key steps:

• Sample Collection A biological sample, such as blood, urine, sputum, or tissue, is collected from the patient. This sample serves as the source of nucleic acids for the test.
• Nucleic Acid Preparation The nucleic acid (either DNA or RNA) is isolated from the collected sample. This step is crucial as it ensures that the target nucleic acid is available for amplification. The preparation may involve various laboratory techniques to extract and purify the nucleic acids.
• Target Amplification Once the nucleic acid is prepared, target amplification is performed. This process involves replicating the specific nucleic acid sequence multiple times, generating numerous copies that can be analyzed. The amplification can be repeated to produce even more copies, enhancing the sensitivity of the test.
• Reporting If target amplification is conducted on multiple nucleic acid sequences, each sequence is reported using the appropriate CPT® code 83898. For the first two sequences amplified using multiplex technology, code 83900 is used, while code 83901 is applied for each additional sequence beyond the first two.

3. Post-Procedure

After the molecular diagnostics test is completed, the results are analyzed and interpreted by qualified laboratory personnel. The findings can provide critical information regarding the presence of specific genetic markers or pathogens, which can influence patient management and treatment decisions. It is essential for healthcare providers to communicate the results to the patient and discuss any necessary follow-up actions or additional testing that may be required based on the findings. Additionally, proper documentation of the procedure and results is vital for compliance and billing purposes.